Achieve Life Sciences, Inc. (ACHV) NASDAQ
4.15
-0.08(-1.89%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
4.15
-0.08(-1.89%)
Currency In USD
Address
1040 West Georgia Street
Vancouver, BC V6E 4H1
Canada
Phone
14256861500
Sector
Healthcare
Industry
Biotechnology
Employees
25
First IPO Date
October 12, 1995
| Name | Title | Pay | Year Born |
| Richard A. Stewart | Chief Executive Officer & Executive Director | 892,132 | 1959 |
| Mark K. Oki | Chief Financial Officer | 425,244 | 1969 |
| Mark L. Rubinstein | Interim Chief Medical Officer | 0 | N/A |
| Craig Donnelly | Chief Operations Officer | 0 | N/A |
| Erik Atkisson | Chief Legal Officer | 0 | 1972 |
| Jerry Wan | VP of Finance & Principal Accounting Officer | 0 | 1982 |
| Jaime Xinos | Chief Commercial Officer | 0 | 1977 |
| Nicole Jones | Vice President of Strategic Communications & Stakeholder Relations | 0 | N/A |
Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes of cytisinicline for smoking cessation and nicotine addiction in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license agreements with Sopharma AD and University of Bristol. The company is based in Vancouver, Canada.